Compare PCB & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCB | CGC |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.1M | 467.3M |
| IPO Year | 2018 | 2023 |
| Metric | PCB | CGC |
|---|---|---|
| Price | $27.95 | $0.97 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $25.50 | N/A |
| AVG Volume (30 Days) | 25.1K | ★ 3.8M |
| Earning Date | 04-23-2026 | 05-29-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | 48.28 | ★ 84.17 |
| EPS | ★ 1.47 | N/A |
| Revenue | $2,899,000.00 | ★ $12,759,000.00 |
| Revenue This Year | $13.73 | $8.27 |
| Revenue Next Year | $9.07 | $15.68 |
| P/E Ratio | $19.07 | ★ N/A |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $19.70 | $0.84 |
| 52 Week High | $30.84 | $2.38 |
| Indicator | PCB | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 46.53 |
| Support Level | $27.31 | $0.96 |
| Resistance Level | $28.99 | $1.23 |
| Average True Range (ATR) | 0.65 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 54.65 | 14.18 |
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.